ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 715067 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 715067; 2) Community: the network communities that were significantly associated with the response to NSC 715067; 3) Molecule: the relationships between components within communities and NSC 715067; 4) MDR: the compounds that were significantly associated with the NSC 715067.

NSC Compound Enrichment Correlation
NSC 665700 Null 0.0222343516878698 0.59937848
NSC 673803 9-Acridinamine, N-[3-[bis(2-hydroxyethyl)amino]propyl]- 7-methoxy-3-nitro- 0.0222343516878698 0.47743688
NSC 681639 Camptothecin Derivative 0.0222343516878698 0.0012723794
NSC 701570 Androst-5-en-17-one, 3-acetyloxy-16-phenylmethylene-, 17-oxime, (3.beta.)- 0.0222343516878698 0.42278669
NSC 714655 Null 0.0222343516878698 0.24007135
NSC 729813 6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt 0.0222343516878698 0.053919072
NSC 75890 1,9-Pyrazoloanthrone 0.0222343516878698 0.15624459
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0244632509325736 0.25543151
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0244632509325736 0.22480649
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0244632509325736 0.57996841
Total:53  Current:26    [First] [Prev] [Next] [Last]